6 completed, 2 unknown, 1 terminated. 9 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Unknown 2, Terminated 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Dexetimide: new trials by email Literature Review of Dexetimide trials Research Report on Dexetimide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cortical Ischemic Stroke and Serotonin Serotonin Uptake Inhibitors, Placebo - Stroke | Phase 2 | Unknown | Insel Gruppe AG, University Hospital Bern | 90 | 2016-08-01 | 2020-03-06 |
| The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients Escitalopram, placebo - GBM, Depression | Phase 2 / Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2015-12-01 | 2015-12-07 |
| The Efficacy of Citalopram Treatment in Acute Stroke Citalopram, Placebo - Stroke, Ischemic | Phase 2 | Completed | University of Aarhus | 642 | 2013-09-01 | 2017-02-24 |
| EScitalopram PIndolol ONset of Action escitalopram, pindolol, escitalopram - Unipolar Depression | Phase 2 / Phase 3 | Terminated | Markus KOSEL | 18 | 2010-10-01 | 2015-05-27 |
| Flushing in Social Anxiety Disorder on Cipralex Cipralex, Placebo - Social Anxiety Disorder | Phase 2 | Completed | START Clinic for Mood and Anxiety Disorders | 71 | 2008-10-01 | 2013-10-30 |
| A Study for Participants With Major Depression LY2216684, Placebo, Escitalopram - Major Depressive Disorder | Phase 2 | Completed | Eli Lilly and Company | 469 | 2006-12-01 | 2018-04-27 |
| Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression S-citalopram, Cognitive behavioral therapy (CBT), TRODAT-1 single photon emission computed tomographic (SPECT) imaging - Depression | Phase 2 / Phase 3 | Completed | University of Pennsylvania | 66 | 2005-10-01 | 2020-04-16 |
| Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients Escitalopram, Placebo - Major Depressive Disorder, Hepatitis C, Chronic | Phase 2 | Completed | Germans Trias i Pujol Hospital | 133 | 2005-03-01 | 2020-08-17 |
| Citalopram in Irritable Bowel Syndrome Citalopram, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Stanford University | 54 | 2001-04-01 | 2017-04-17 |
Depression (3) · Depressive Disorder, Major (2) · Stroke (2) · Depressive Disorder (1) · Hepatitis C, Chronic (1) · Irritable Bowel Syndrome (1) · Ischemic Stroke (1) · Phobia, Social (1)
Eli Lilly and Company (1) · Germans Trias i Pujol Hospital (1) · Insel Gruppe AG, University Hospital Bern (1) · Markus KOSEL (1) · START Clinic for Mood and Anxiety Disorders (1) · Stanford University (1) · Tel-Aviv Sourasky Medical Center (1) · University of Aarhus (1) · University of Pennsylvania (1)
United States (3) · Switzerland (2) · Canada (1) · Denmark (1) · Israel (1) · Romania (1) · Spain (1)
Boris Modrau, M.D. (1) · Crisanto Diez-Quevedo, MD (1) · Grethe Andersen, DSMc (1) · Helle Iversen, DSMc (1) · Jay D. Amsterdam, MD (1) · Kristian L Kraglund, M.D. (1) · Markus Kosel, MD-PhD (1) · Martin A Katzman, MD (1) · Rachel Grossman, MD (1) · Ramon Planas, MD (1) · Roland Wiest (1) · Uri Ladabaum, M.D., M.S. (1)
PMID 21034680, PMID 30355209, PMID 33032615, PMID 36997260
2016 (1), R34MH070753 (1)